Abstract:
A cosmetic composition comprising sargachromenol is provided to induce apoptosis on human keratinocyte significantly, thereby being usefully used in order to prevent and improving skin diseases caused by skin aging, photo-aging and pigmentation. A cosmetic composition for preventing and improving skin diseases comprises sargachromenol represented by a formula(1) and isolated from Sargassum sagamianum as an effective ingredient, wherein the skin disease is a skin disease caused by proliferation of keratinocyte such as skin aging, photo-aging, and a pigmentation disease.
Abstract:
본 발명은 피부질환 및 피부암의 예방 또는 치료용 약학적 조성물에 관한 것이다. 보다 구체적으로, 본 발명은 하기 화학식 I로 표시되는 사가퀴노익산(Sargaquinoic acid)을 유효성분으로 함유하는 피부질환 및 피부암의 예방 또는 치료용 약학적 조성물에 관한 것이다.
Abstract:
A pharmaceutical composition containing Sargaquinoic acid for preventing or treating skin disease and skin cancer is provided to prevent and treat diseases associated with hyperplastic skin cells by inducing cytotoxicity and apoptosis of skin cells, and promotes apoptosis by irradiating ultraviolet rays. A pharmaceutical composition for preventing or treating skin disease and skin cancer contains Sargaquinoic acid represented by the formula(I) or its pharmaceutically acceptable salt as an effective ingredient, wherein the medicinal effects of the pharmaceutical composition are increased by irradiating ultraviolet rays and the skin disease is hyperplastic skin disease including psoriasis, fishskin disease, Bowen's disease, papilloma, eczema, eczema, atopic dermatitis, acne vulgaris, dermatitis, lichen planus, striatus, foot hyperkeratosis, dark spots, actinic keratosis, skin aging and photoaging.